T cells are activated through the recognition of antigen peptides presented on MHC complexes on antigen presenting cells (APCs). This leads to T cell proliferation and differentiation into effector T cells. Cytotoxic T cells recognize endogenous antigens on MHC I to kill infected cells, while helper T cells recognize exogenous peptides on MHC II and secrete cytokines to stimulate macrophage activation or B cell antibody production. Full T cell activation requires both antigen recognition by the TCR and co-stimulatory signaling between molecules such as B7 and CD28.
T-Cell Activation
• Concept of immune response
• T cell-mediated immune response
• B cell-mediated immune response
I. Concept of immune response
• A collective and coordinated response to the introduction of foreign substances in an individual mediated by the cells and molecules in the immune system.
II. T cell-mediated immune response
• Cell-mediated immunity is the arm of the adaptive immune response whose role is to combat infection of intracellular pathogens, such as intracellular bacteria (mycobacteria, listeria monocytogens), viruses, protozoa, etc.
introduction of adaptive immunity. classification of adaptive immunity, factor affecting it and mechanism of adaptive immunity comparison between adaptive immunity and innate immunity. characteristic of adaptive immunity . cell mediated immune responses immunoglobulins
types of immunoglobulins. functions of immunoglobulins, hypersensitivity reactions
T-Cell Activation
• Concept of immune response
• T cell-mediated immune response
• B cell-mediated immune response
I. Concept of immune response
• A collective and coordinated response to the introduction of foreign substances in an individual mediated by the cells and molecules in the immune system.
II. T cell-mediated immune response
• Cell-mediated immunity is the arm of the adaptive immune response whose role is to combat infection of intracellular pathogens, such as intracellular bacteria (mycobacteria, listeria monocytogens), viruses, protozoa, etc.
introduction of adaptive immunity. classification of adaptive immunity, factor affecting it and mechanism of adaptive immunity comparison between adaptive immunity and innate immunity. characteristic of adaptive immunity . cell mediated immune responses immunoglobulins
types of immunoglobulins. functions of immunoglobulins, hypersensitivity reactions
Major Histo compatibility Complex of Genes /certified fixed orthodontic cours...Indian dental academy
The Indian Dental Academy is the Leader in
continuing dental education , training dentists
in all aspects of dentistry and offering a wide
range of dental certified courses in different
formats.
Indian dental academy provides dental crown &
Bridge,rotary endodontics,fixed orthodontics,
Dental implants courses.for details pls visit
www.indiandentalacademy.com ,or call
0091-9248678078
immunological tolerance can be divided into two parts. they are central tolerance and peripheral tolerance. this slide contains information on development of central tolerance which include both B cell and T cell central tolerance.
Biochemistry of Hair fall, A complete review of hair fall cause, Types, Current methods of treatment, Natural methods of treatment,
for more detail text see :https://iiopinion.blogspot.in/2017/01/hair-fall-scientific-way-of-treatment.html
Non-Specific Immune Response, Innate immunity, inherent immunity, Role in overall immunity of individual, Significance, components involve in Non-Specific Immune Response,
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
2. T Cell-Mediated Immunity
Headings
• T Cell Activation
• Properties of Effector T Cells
• Cytotoxic T Cells
• Macrophage Activation by Th1
(Inflammatory T) Cells
This Presentation
will help you
see how T cells are
activated by
antigen presented
on APC.
understand the
properties and
functions of
effector T cells.
3. Headlines in Nutshell
Singling between APC & T
cells depends upon CAMs
CAMs allow them to come
closure, so that Ag specific
interaction can occur, if it
would be!
After this adhesion, MHC-
peptide & TCR come closure
to bind up
This is further facilitated by
LFA-1 for more strong
binding
Meanwhile, T cell, in complex,
starts dividing & daughter
cells remain attached to them
& receive activation signal.
4. Self-MHC restriction of the T-cell receptor
(TCR). A particular TCR is specific for both an
antigenic peptide and a self-MHC molecule.
5. I. Importance of T lymphocytes
Both T and B cells are needed to generate an Ab response
Helper T cells activate B cells to produce Ab
CTC are the other type of T cell, which actively kill other
cells
T cells are clonally selected via Ag recognition by the T cell
receptor
T cell Ag recognition is similar (e.g. TCR, Ig are
homologous) to that in B cells, but distinct in mechanism
T cells develop in the thymus (this is the principle function
of this organ)
6. Effector Cells in Adaptive Immunity
Effector
T Cell
Pathogen
Location
Antigen
Presentation
Target Cell
Action
Cellular
Immunity
Tc CD8
cytotoxic
Cytoplasm
Infected cell
MHC I
Infected cell
apoptosis
Th1 CD4
inflammatory
Macrophage
vesicles
Macrophage
MHC II
Macrophage
activation to
kill pathogen
Humoral
Immunity Th2 CD4
helper
Extracellular APC MHC II
B cell antibody
production
7. T Cell Activation
Adaptive T cell-mediated
immunity is driven by
activation of T cells:
cytotoxic T cells activated by
endogenous antigen to
kill infected cells,
helper T cells activated by
exogenous antigen to
stimulate MΦ killing of
endosomal pathogens.
Adaptive humoral immunity
also usually involves T cell
activation to produce
cytokines that stimulate B
cell antibody synthesis.
8. T Cells Recognize Ag by a Unique Mechanism
T cells recognize linear 9-10 aa
peptide sequences
T cells only recognize Ag’s
presented on the surfaces of APC
MHC restriction: the MHC allele
expressed on the APC must be
correct to stimulate T cells
9. Major Histocompatibility Complex
(A) Discovery of the MHC
discovered by mapping cell surface antigen
responsible for tumor graft rejection
the surface antigen is the MHC, recipient
and donor must have matching MHC’s for
graft to be accepted
the MHC is called H-2 in mice and HLA in
humans
10. Major Histocompatibility Complex
The MHC locus encodes three classes of molecules
MHC
Class I
Dimer of chain and 2m
(not in locus)
Three types, HLA A, B, C (in
mouse, H-2K, -2D, -2L)
Expressed on all cell surfaces
except neurons and RBC
Special subclass Ib is
nonpolymorphic and tissue
specific, related to bacterial
pathogen response
MHC
Class II
Heterodimer of and
chains
Three types DP, DQ, DR (in
mouse I-A, I-E)
Only expressed on APC’s
MHC
Class III
related to complement and
cytokines, irrelevant to this
topic
11. MHC genes are highly polymorphic
polymorphism in HLA genes for both
class I and II is “balanced”
nomenclature: HLA A*(allele #) (in
mouse, superscript is allele type)
most variation is localized to Ag
binding domains (1 2 in class I, 1
1 in class II
12. MHC restriction is mediated by specific
recognition by the TCR
T cells are activated only if APC expresses
the correct MHC
Can test which MHC is responsible directly
(correlate genotypes with response) or by
specific blocking with antibodies
Only one TCR needed to recognize both Ag
and MHC
13. IV. The T Cell Receptor
Discovered by clonotypic Ab and subtractive
hybridization
The TCR is made of two chains, , similar to Ig;
each have one variable and one constant region
TCR gene rearrangement
rearranges by VJ, by VDJ
using the RAG’s
junctional diversity is important
but hypermutation is not
14. How Ag is recognized
APCs must process antigen before recognition occurs (hence, a
time lag)
MHC molecules bind a single, short Ag peptides of 9-10 aa (not
TCR!)
MHC molecules are specific in binding only certain peptides
Complexity of immunogens and diversity of MHC expressed
allows response to lots of pathogens, but susceptibility varies
with MHC genotype
The 1 and 2 domains of MHC form a catcher’s mitt with a
groove to bind peptides; anchor positions give great specificity
at those residues
15. Model for Ag Recognition by T Cells
Uptake of Ag by APC
Processing of Ag (proteolysis)
Presentation of Ag peptide fragment
on MHC
Recognition of MHC-Ag complex by
T cells (this is MHC restricted)
16. VII. T Cell Subsets
Two classes
of T cells
1) CD4+
Recognize exogenous Ag on MHC II on
APC’s
Release cytokines (IL2 T cell
proliferation, IL4,5,6 B cell
activation)
Ag taken up by endocytosis, cleaved in
lysosome
For B cells, Ag binding to surface Ig
results in rapid uptake of Ag
Invariant chain (Ii) blocks MHC II
binding site until fusion with lysosome
2) CD8+
Recognize endogenous (viral) Ag
on MHC I on all cells (except
neuron, RBC)
Cause cytolysis of infected cell
Viral proteins cleaved by
protesome, enters ER through
TAP1/2 transporters
17. VIII. T cell/APC interaction
The CD’s interact specifically
with their MHC; also coupled
to signaling pathway (lck)
Interactions between
accessory proteins are
required for T cell activation
Superantigens (e.g. some
bacterial endotoxins)
promote T cell activation by
binding TCR and MHC
outside of cleft
huge number of T cells
activated eventually lead to
toxic shock syndrome
IX. Other
Ag specific T cells can be
detected with labeled MHC or
MHC-Ig molecules
HIV coat protein gp120 binds
CD4, first step in virus infection
18. Key Adhesion Molecules in T-Cell Activation
Ig Superfamily
Adhesion Molecule
Tissue Distribution Integrin Legend
CD2 (LFA-2) T cells LFA-3 on APC
ICAM-1 (CD 54)
Activated endothelium
dendritic cells
T cells
LFA-1 on T cells
MAC-1 on macrophages
ICAM-2 (CD102) Resting endothelium LFA-1 on T cells
ICAM-3 (CD50) Naïve T cells
DC-SIGN on dendritic
cells
LFA-3 (CD58)
Lymphocytes
APC
CD2 on T cells
24. Lymphocytes Trafficking
Definition: “Trafficking of lymphocytes
between tissue, the blood stream and lymph
nodes enable antigen sensitive cells at which
response is occurring”
Recognisation of vascular adressins on vascular
endothelium in secondary lymphoid organ
26. As the T-Cells Adhere to
APC
Movements of TCR towards
the Peptide~MHC Starts
They come closure to each
other and bind
Thus the complex so formed
will be [T-CELLS-TCR-
PEPTIDE~MHC-APC]
• LFA-1 changes its confirmation
Binding become tighter
• This is required for the long time
to Activate the cells
After the receiving
stimulation signal T cells
starts dividing and its
progeny still attached to the
mother cells and received
activation signals
To activate the T cells APC
has to delivered two signals
• To TCR via MHC~Peptide
Complex
• Co-stimulatory signal via
interaction of B7 to CD-28
27. In general the same cell must delivered the antigenic and co-stimulatory signal
simultaneously for the activation of the T cell.
• Not all self reactive T cells are deleted in the Thymus
• Since some self antigens are appropriate in the other
tissues
This is because :
Now if Ag & Co-stimulatory signal could be delivered separately, T cells could
be stimulated by SELF PEPTIDE on Non APC & become fully activated to
make an auto immune response by an APC presenting different peptide
The T cells which binds to Ag and couldn’t get co stimulatory signal become
ANERGIC and can't responds in future even if proper co stimulation is
received
Why these cells are inactivated without killed is not known !!!!!!!!!!!
APC=DC,Mᶲ or B cells:
DC deliver both signal and are the best
APC and are the responsible for the
activation of the most of the naïve cells
28. CD-40L
T-Cells
Ag & Co-Stimulatory
Signals
Activated
T Cells
Express
Other
receptors
Enhance Co
stimulation
APC
CD-40
To provide
more co
stimulation
Express More B7
molecules
To send activation
signals to T cells
Activate
M &
B- Cells
Further Interaction of APC & T Cells
29. The immune response therefore depends upon PUSH of the
antigen stimulation to activate T cells in to effectors cells and
PULL of negative signal that curtail T cells response
B7CTAL-4
ICOS
4-IBB/CD-137 4-1BBL
To further activate T &
APC
LICOS
Inducible co stimulator
Binds 20 times more
avidly then CD-28 send
activation signals